100 related articles for article (PubMed ID: 28879065)
21. Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.
Marion CR; Wang J; Sharma L; Losier A; Lui W; Andrews N; Elias JA; Kazmierczak BI; Roy CR; Dela Cruz CS
Infect Immun; 2016 Jul; 84(7):2094-2104. PubMed ID: 27141083
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamic and protective properties of a murine lipopolysaccharide-specific monoclonal antibody in experimental Pseudomonas aeruginosa pneumonia in mice.
Oishi K; Sonoda F; Miwa H; Tanaka H; Watanabe K; Matsumoto K; Pollack M
Microbiol Immunol; 1991; 35(12):1131-41. PubMed ID: 1808464
[TBL] [Abstract][Full Text] [Related]
23. Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection.
Wuerth KC; Falsafi R; Hancock REW
PLoS One; 2017; 12(11):e0187565. PubMed ID: 29107983
[TBL] [Abstract][Full Text] [Related]
24. Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas.
Feola DJ; Garvy BA; Cory TJ; Birket SE; Hoy H; Hayes D; Murphy BS
Antimicrob Agents Chemother; 2010 Jun; 54(6):2437-47. PubMed ID: 20231397
[TBL] [Abstract][Full Text] [Related]
25. Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2.
Sadikot RT; Zeng H; Azim AC; Joo M; Dey SK; Breyer RM; Peebles RS; Blackwell TS; Christman JW
Eur J Immunol; 2007 Apr; 37(4):1001-9. PubMed ID: 17330822
[TBL] [Abstract][Full Text] [Related]
26. TLR4-interacting SPA4 peptide improves host defense and alleviates tissue injury in a mouse model of Pseudomonas aeruginosa lung infection.
Awasthi S; Singh B; Ramani V; Xie J; Kosanke S
PLoS One; 2019; 14(1):e0210979. PubMed ID: 30689633
[TBL] [Abstract][Full Text] [Related]
27. Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat.
Roux D; Gaudry S; Dreyfuss D; El-Benna J; de Prost N; Denamur E; Saumon G; Ricard JD
Crit Care Med; 2009 Mar; 37(3):1062-7. PubMed ID: 19237918
[TBL] [Abstract][Full Text] [Related]
28. Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model.
Thomsen K; Christophersen L; Bjarnsholt T; Jensen PØ; Moser C; Høiby N
J Cyst Fibros; 2016 Mar; 15(2):171-8. PubMed ID: 26303991
[TBL] [Abstract][Full Text] [Related]
29. Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa.
Ballinger MN; Paine R; Serezani CH; Aronoff DM; Choi ES; Standiford TJ; Toews GB; Moore BB
Am J Respir Cell Mol Biol; 2006 Jun; 34(6):766-74. PubMed ID: 16474098
[TBL] [Abstract][Full Text] [Related]
30. IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice.
Carrigan SO; Junkins R; Yang YJ; Macneil A; Richardson C; Johnston B; Lin TJ
J Immunol; 2010 Sep; 185(6):3602-9. PubMed ID: 20720199
[TBL] [Abstract][Full Text] [Related]
31. Critical role of the small GTPase RhoA in the development of pulmonary edema induced by Pseudomonas aeruginosa in mice.
Carles M; Lafargue M; Goolaerts A; Roux J; Song Y; Howard M; Weston D; Swindle JT; Hedgpeth J; Burel-Vandenbos F; Pittet JF
Anesthesiology; 2010 Nov; 113(5):1134-43. PubMed ID: 20938335
[TBL] [Abstract][Full Text] [Related]
32. Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats.
Song Z; Johansen HK; Faber V; Moser C; Kharazmi A; Rygaard J; Høiby N
Antimicrob Agents Chemother; 1997 May; 41(5):961-4. PubMed ID: 9145852
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
34. Nebulized anticoagulants limit coagulopathy but not inflammation in pseudomonas aeruginosa-induced pneumonia in rats.
Cornet AD; Hofstra JJ; Vlaar AP; van den Boogaard FE; Roelofs JJ; van der Poll T; Levi M; Groeneveld AB; Schultz MJ
Shock; 2011 Oct; 36(4):417-23. PubMed ID: 21897338
[TBL] [Abstract][Full Text] [Related]
35. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model.
Broquet A; Roquilly A; Jacqueline C; Potel G; Caillon J; Asehnoune K
Crit Care Med; 2014 Jun; 42(6):e441-50. PubMed ID: 24732238
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte-macrophage colony stimulatory factor enhances the pro-inflammatory response of interferon-γ-treated macrophages to Pseudomonas aeruginosa infection.
Singh S; Barr H; Liu YC; Robins A; Heeb S; Williams P; Fogarty A; Cámara M; Martínez-Pomares L
PLoS One; 2015; 10(2):e0117447. PubMed ID: 25706389
[TBL] [Abstract][Full Text] [Related]
37. Adipose Tissue-Derived Mesenchymal Stem Cells Attenuate Pulmonary Infection Caused by Pseudomonas aeruginosa via Inhibiting Overproduction of Prostaglandin E2.
Mao YX; Xu JF; Seeley EJ; Tang XD; Xu LL; Zhu YG; Song YL; Qu JM
Stem Cells; 2015 Jul; 33(7):2331-42. PubMed ID: 25788456
[TBL] [Abstract][Full Text] [Related]
38. Role of cystic fibrosis transmembrane conductance regulator in pulmonary clearance of Pseudomonas aeruginosa in vivo.
Chroneos ZC; Wert SE; Livingston JL; Hassett DJ; Whitsett JA
J Immunol; 2000 Oct; 165(7):3941-50. PubMed ID: 11034402
[TBL] [Abstract][Full Text] [Related]
39. Increased Myeloid Cell Production and Lung Bacterial Clearance in Mice Exposed to Cigarette Smoke.
Basilico P; Cremona TP; Oevermann A; Piersigilli A; Benarafa C
Am J Respir Cell Mol Biol; 2016 Mar; 54(3):424-35. PubMed ID: 26273827
[TBL] [Abstract][Full Text] [Related]
40. Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.
Speert DP; Wong SY; Macdonald M; Sargeant R
Behring Inst Mitt; 1997 Feb; (98):274-82. PubMed ID: 9382751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
